Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Luca Miele.

Newcastle AuthorsTitleYearFull text
Dr Olivier Govaere
Professor Dina Tiniakos
Professor Alastair Burt
Marco Zaki
Dr Luca Miele
et al.
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease2024
Dr Luca Miele
Professor Helen Reeves
Rare ATG7 genetic variants predispose patients to severe fatty liver disease2022
Dr Massimo Younes
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Alastair Burt
Marco Youssef William Zaki
et al.
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease2021
Dr Luca Miele
Professor Quentin Anstee
Professor Helen Reeves
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores2021
Dr Massimo Younes
Dr Olivier Govaere
Dr Luca Miele
Dr Dina Tiniakos
Professor Alastair Burt
et al.
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease2020
Misti McCain
Dr Luca Miele
Professor Helen Reeves
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease2019
Misti McCain
Dr Luca Miele
Dr Paula Iruzubieta
Professor Helen Reeves
Professor Quentin Anstee
et al.
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals2017
Dr Lucy Walker
Professor Ann Daly
Dr Luca Miele
Professor Quentin Anstee
Professor Helen Reeves
et al.
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease2017
Dr Luca Miele
Dr David Sheridan
Diverse Impacts of the rs58542926 E167K Variant in TM6SF2 on Viral and Metabolic Liver Disease Phenotypes2016
Professor Helen Reeves
Dr Luca Miele
Professor Quentin Anstee
Telomerase reverse transcriptase mutations are associated with hepatocellular carcinoma in nash2015
Dr Luca Miele
Professor Chris Day
Gut-liver Axis and Microbiota in NAFLD: Insight Pathophysiology for Novel Therapeutic Target2013
Dr Gillian Patman
Laura Pascoe
Dr Luca Miele
Douglas Hui
Professor Alastair Burt
et al.
Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease2012
Laura Pascoe
Dr Luca Miele
Professor Helen Reeves
Kruppel like factor 6 (KLF6) regulates heaptic insulin resistance (HEP-IR)2010
Dr Joseph Gray
Dr Dipanker Chattopadhyay
Dr Gary Beale
Dr Gillian Patman
Dr Luca Miele
et al.
A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease2009
Dr Gary Beale
Ahmad Alserri
Dr Luca Miele
Dr Gillian Patman
Professor Ann Daly
et al.
Claudin 10 (CLDN10) - a Candidate Suceptibility Gene for NAFLD Progression2009
Dr Luca Miele
Professor Chris Day
Increased Intestinal Permeability and Tight Junction Alterations in Nonalcoholic Fatty Liver Disease2009
Dr Gary Beale
Laura Pascoe
Dr Luca Miele
Professor Mark Walker
Professor Chris Day
et al.
The Kruppel-Like Factor 6 (KLF6) Genotype Which is Associated With NAFLD Progression is Associated with Higher Fasting Serum Glucose Levels in Healthy Individuals2009
Dr Luca Miele
Dr Gary Beale
Dr Gillian Patman
Julian Leathart
Professor Chris Day
et al.
The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease2008
Dr Luca Miele
Alcoholic and nonalcoholic forms of fatty liver disease2007
Dr Gary Beale
Dr Luca Miele
Professor Helen Reeves
Professor Chris Day
Differential expression of GSTT1 and GSTT2 is associated with more advanced fibrosis in patients with NAFLD2007
Dr Luca Miele
Fat in the liver and insulin resistance2007
Dr Luca Miele
Dr Gary Beale
Julian Leathart
Professor Chris Day
Professor Helen Reeves
et al.
The KLF6 (IVS1-27G > a) polymorphism is associated with non-progressive NAFLD2007